AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2018

Mar 1, 2018

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2018-02-13

Reporting Person: Rodino Peter W. III (Dir Govt Relations/Sectry)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-13	Options to buy Common Stock	$0.37	A	173423	Acquired	2028-02-13	Common Stock (173423)	Direct

F1: This option is being issued by senior management in exchange for a voluntary 40% deferral in salary.